Document Detail


Reversal of cardiac hypertrophy by medical treatment.
MedLine Citation:
PMID:  3158269     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Reversal of left ventricular hypertrophy in hypertensive patients has been proven to follow effective blood pressure control by some antihypertensive drugs. This reversal does not depend solely on the degree of pressure reduction but is also modulated by other factors including, among others, stability of blood pressure control, degree of cardioadrenergic stimulation, and individual variations due to genetic background and possible age. Regression of left ventricular hypertrophy is most likely to occur when the reduction in arterial pressure and peripheral resistance can be maintained without induced reflex cardiac stimulation. Left ventricular performance at rest was not depressed by the reduction in cardiac mass but remained normal both in absolute terms and in relation to changes in LV end-systolic stress.
Authors:
R C Tarazi; F M Fouad
Related Documents :
16567599 - Relationship between accurate auscultation of a clinically useful third heart sound and...
2144489 - Prevalence and determinants of left ventricular diastolic filling abnormalities in an u...
6769329 - Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgita...
10611919 - An adult case with an abnormal right ventricular structure causing intraventricular pre...
6825239 - Correlation of echocardiographic wall stress and left ventricular pressure and function...
8281969 - Origin and mechanisms of heart failure in hypertensive patients: left ventricular remod...
15364849 - Importance of mitral valve second-order chordae for left ventricular geometry, wall thi...
9415909 - Tourniquet pressures on pediatric patients: a clinical study.
2143129 - Hemodynamic effects of atrial natriuretic factor in young and elderly subjects.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annual review of medicine     Volume:  36     ISSN:  0066-4219     ISO Abbreviation:  Annu. Rev. Med.     Publication Date:  1985  
Date Detail:
Created Date:  1985-06-17     Completed Date:  1985-06-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985151R     Medline TA:  Annu Rev Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  407-14     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antihypertensive Agents / therapeutic use*
Cardiomegaly / drug therapy*,  physiopathology
Coronary Circulation
Humans
Hypertension / complications*,  pathology,  physiopathology
Myocardial Contraction
Myocardium / pathology
Rats
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Staphylococcal toxin syndromes.
Next Document:  Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urin...